Omnicell, Inc. announced that Texas Children's Hospital will expand its Omnicell® automated medication management platform, with the addition of new automation for pharmacy and patient care areas, leveraging streamlined workflows and safety initiatives to support improved patient care and enhanced pharmacy performance. According to an American Society of Health-system Pharmacists national survey, pharmacy directors estimate that 76% of staff time is spent on non-clinical activities.1 An automated medication management infrastructure empowers pharmacists, nurses, clinicians, and pharmacy staff to focus on patient and clinician satisfaction, leading to improved patient care, fewer errors, enhanced safety, and new opportunities for growth. Texas Children's has selected Omnicell's expert services, part of the Company's autonomous approach to medication management, to support improved efficiency, regulatory compliance and outcomes. Leveraging these expert resources will allow the health system to address labor challenges and implement best practices to achieve clinical and financial goals. XR2 as a Service combines the technology of Omnicell'sXR2 Automated Central Pharmacy System with dedicated resources to support a more comprehensive approach to managing pharmacy medication inventory. Designed to scale with organizational growth, XR2 will allow Texas Children's to maximize the return on pharmacy investment, reducing administrative burden and allowing pharmacy leadership to focus on clinical care. The health system will also be implementing Omnicell'sRobotic IV Insourcing Solution (RIIS), a unique program that combines advanced robotic technology, data and expertly trained pharmacy technician staff into a comprehensive, turnkey package that provides a streamlined path for hospitals to insource their sterile compounding operations. Insourcing IV compounding can provide up to a 66% reduction in costs, based on ROI modeling.